94 related articles for article (PubMed ID: 16503420)
41. Circulating regulatory anti-T cell receptor antibodies in patients with myasthenia gravis.
Jambou F; Zhang W; Menestrier M; Klingel-Schmitt I; Michel O; Caillat-Zucman S; Aissaoui A; Landemarre L; Berrih-Aknin S; Cohen-Kaminsky S
J Clin Invest; 2003 Jul; 112(2):265-74. PubMed ID: 12865414
[TBL] [Abstract][Full Text] [Related]
42. Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides.
Howell MD; Winters ST; Olee T; Powell HC; Carlo DJ; Brostoff SW
Science; 1989 Nov; 246(4930):668-70. PubMed ID: 2814489
[TBL] [Abstract][Full Text] [Related]
43. Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides.
Fontoura P; Garren H; Steinman L
Int Rev Immunol; 2005; 24(5-6):415-46. PubMed ID: 16318989
[TBL] [Abstract][Full Text] [Related]
44. Prospects for a T-cell receptor vaccination against myasthenia gravis.
Cohen-Kaminsky S; Jambou F
Expert Rev Vaccines; 2005 Aug; 4(4):473-92. PubMed ID: 16117705
[TBL] [Abstract][Full Text] [Related]
45. Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis.
Offner H; Adlard K; Zamora A; Vandenbark AA
J Clin Invest; 2000 May; 105(10):1465-72. PubMed ID: 10811854
[TBL] [Abstract][Full Text] [Related]
46. FK506 as an adjuvant of tolerogenic DNA vaccination for the prevention of experimental autoimmune encephalomyelitis.
Kang Y; Zhao J; Liu Y; Chen A; Zheng G; Yu Y; Mi J; Zou Q; Wang B
J Gene Med; 2009 Nov; 11(11):1064-70. PubMed ID: 19688809
[TBL] [Abstract][Full Text] [Related]
47. Requirement for CD8+ cells in T cell receptor peptide-induced clonal unresponsiveness.
Gaur A; Ruberti G; Haspel R; Mayer JP; Fathman CG
Science; 1993 Jan; 259(5091):91-4. PubMed ID: 8418501
[TBL] [Abstract][Full Text] [Related]
48. Immunomodulation of experimental allergic encephalomyelitis.
Arnon R; Teitelbaum D
Isr J Med Sci; 1993; 29(2-3):175-81. PubMed ID: 7682204
[No Abstract] [Full Text] [Related]
49. Carbonyl iron: a new adjuvant for experimental autoimmune diseases.
Levine S; Sowinski R
J Immunol; 1970 Dec; 105(6):1530-5. PubMed ID: 5483831
[No Abstract] [Full Text] [Related]
50. Immunity to T-cell receptor : suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor.
Waisman A
Methods Mol Med; 2000; 29():397-403. PubMed ID: 21374337
[TBL] [Abstract][Full Text] [Related]
51. T cell receptor peptide therapy for autoimmune disease.
Vandenbark AA; Chou YK; Bourdette DN; Whitham R; Hashim GA; Offner H
J Autoimmun; 1992 Apr; 5 Suppl A():83-92. PubMed ID: 1503638
[TBL] [Abstract][Full Text] [Related]
52. Antigenized antibodies expressing Vbeta8.2 TCR peptides immunize against rat experimental allergic encephalomyelitis.
Musselli C; Daverio-Zanetti S; Zanetti M
J Immune Based Ther Vaccines; 2004 Nov; 2(1):9. PubMed ID: 15541175
[TBL] [Abstract][Full Text] [Related]
53. Seven surprises in the TCR-centred regulation of immune responsiveness in an autoimmune system.
Sercarz E; Maverakis E; van den Elzen P; Madakamutil L; Kumar V
Novartis Found Symp; 2003; 252():165-71; discussion 171-6, 203-10. PubMed ID: 14609218
[TBL] [Abstract][Full Text] [Related]
54. T cell receptors in autoimmune disease as targets for immune intervention.
Acha-Orbea H; Steinman L; McDevitt HO
Genome; 1989; 31(2):656-61. PubMed ID: 2483695
[TBL] [Abstract][Full Text] [Related]
55. Immunoregulation of autoimmune disease by vaccination with T cell receptor peptides.
Brostoff SW; Howell MD
Ann N Y Acad Sci; 1991 Dec; 636():71-8. PubMed ID: 1793232
[TBL] [Abstract][Full Text] [Related]
56. Management of early inflammatory arthritis. Intervention with immunomodulatory agents: T cell vaccination.
Kingsley G; Panayi GS
Baillieres Clin Rheumatol; 1992 Jun; 6(2):435-54. PubMed ID: 1525847
[TBL] [Abstract][Full Text] [Related]
57. Metallic tin is an adjuvant for anaphylaxis in rats.
Levine S; Saltzman A
Biol Trace Elem Res; 2004 Jun; 98(3):275-7. PubMed ID: 15131323
[TBL] [Abstract][Full Text] [Related]
58. T cell receptor usage in autoimmune disease.
Olive C
Immunol Cell Biol; 1995 Aug; 73(4):297-307. PubMed ID: 7493765
[TBL] [Abstract][Full Text] [Related]
59. Successful prevention of retrocochlear hearing loss in murine experimental allergic encephalomyelitis with T cell receptor Vbeta8-specific antibody.
Suzuki M; Cheng KC; Krug MS; Yoo TJ
Ann Otol Rhinol Laryngol; 1998 Nov; 107(11 Pt 1):917-27. PubMed ID: 9823840
[TBL] [Abstract][Full Text] [Related]
60. TCR peptide therapy in human autoimmune diseases.
Vandenbark AA; Morgan E; Bartholomew R; Bourdette D; Whitham R; Carlo D; Gold D; Hashim G; Offner H
Neurochem Res; 2001 Jun; 26(6):713-30. PubMed ID: 11519731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
